The development of positive inotropic agents for chronic heart failure: How have we gone astray?
- 1 October 1993
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 22 (4) , A119-A126
- https://doi.org/10.1016/0735-1097(93)90474-f
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart FailureNew England Journal of Medicine, 1989
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.Circulation, 1984
- Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure.Circulation, 1984
- Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.Circulation, 1984
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Heart Failure in OutpatientsNew England Journal of Medicine, 1982
- Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist PirbuterolNew England Journal of Medicine, 1981
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978